The Independent Voice of
European Private Equity

Advanced Search

KKR invests in Impilo-backed Immedica Pharma

Xhulio Ismalaj 23 April 2024

Global investment firm KKR has invested in Impilo-backed Immedica Pharma through its $4bn KKR Health Care Strategic Growth Fund II.

Next article »

« Previous article

Related Articles

Hypax carves out Precision Colour Printing from Claverley Group

03/05/24

Bluewater sells Rovop to US marine transportation business

03/05/24

Nordian merges spun-off food specialists to form Benelux-focused food group

03/05/24

CapMan Growth’s third fund hits €130m hard-cap

03/05/24

PAI Partners carves out Fresenius Vamed’s European rehabilitation business

03/05/24

Alto Partners and Arca Fondi boost PE portfolio with acquisition of Eurosirel

03/05/24